Recurrent Diffuse Midline Glioma, H3 K27M-Mutant
1 clinical trials · Condition
◉ Watch Recurrent Diffuse Midline Glioma, H3 K27M-Mutant
| Record | Firm | Date |
|---|---|---|
| Combination Therapy for the Treatment of Diffuse Midline Gliomas (NCT05009992) | University of California, San Francisco | 2021-10-20 |
Track Recurrent Diffuse Midline Glioma, H3 K27M-Mutant automatically
Every clearance here is in the API, with alerts when new ones post.